A comprehensive new analysis published in Nature Reviews Disease Primers provides clinicians with updated, evidence-based guidance on osteomyelitis—a serious inflammatory bone disease resulting from invasive bacterial infection. The review by Cassat and colleagues synthesizes current epidemiological data, diagnostic advances, and treatment protocols for this challenging condition that affects an estimated 2-5 per 10,000 individuals annually in developed countries. The analysis addresses critical clinical concerns including the rising prevalence of antimicrobial resistance, evolving diagnostic strategies, and emerging treatment approaches. By consolidating the most recent scientific evidence, this comprehensive review offers healthcare providers essential insights for improving patient outcomes in osteomyelitis management across diverse clinical settings. Read the full article on GMJ Newsroom.
Was this article helpful?
